Join us for a webinar hosted by the Brain Tumor Epidemiology Consortium (BTEC). Dr. Ching Lau, MD, PhD, will present “Recent findings in the pathogenesis of pediatric ependymoma,” on April 12, 2021, from 2:00 – 3:00 pm EDT. Registration is free: https://www.eventbrite.com/e/recent-findings-in-the-pathogenesis-of-pediatric-ependymoma-tickets-145910545369.
Ching Lau, M.D., Ph.D. is a physician-scientist and is the Martin J. Gavin Endowed Chair and Chief of Pediatric Hematology/Oncology at Connecticut Children’s Medical Center and Professor of Pediatrics at Jackson Laboratory for Genomic Medicine and University of Connecticut School of Medicine. He was the former inaugural Co-Leader of the Pediatrics Program of the Dan L. Duncan Cancer Center at Baylor College of Medicine. Dr. Lau graduated from Rice University with a B.A. in Chemistry and subsequently received his Ph.D. in Pharmacology and M.D. from Harvard Medical School. He was a post-doctoral fellow in Cancer Genetics at Dana-Farber Cancer Center. He completed his Pediatrics Residency and Pediatric Hematology-Oncology Fellowship at Texas Children’s Hospital, Baylor College of Medicine. His research interests include the molecular biology of pediatric brain and bone tumors and the clinical applications of genomic technologies. He is a strong advocate for team science research in academia and is experienced in leading NCI-funded multi-disciplinary teams of research. Most recently he led an international team of investigators to successfully compete for an award through the NIH Kids First Program to study the genetic predisposition of intracranial germ cell tumors. Dr. Lau has published more than 150 papers in prestigious peer-reviewed journals on cancer genetics and genomics including a recent report on the epigenomic effects of the C11orf95/RELA fusion protein in supratentorial ependymoma. He is a highly sought-after speaker who has given more than 120 invited lectures in international and national meetings.